title: Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen.
abstract: Previously we have shown that THP-1 cells synthesize matrix metalloproteinase-9 (MMP-9) where a fraction of the enzyme is strongly linked to a proteoglycan (PG) core protein. In the present work we show that these pro-MMP-9.PG heteromers have different biochemical properties compared with the monomeric form of pro-MMP-9. In these heteromers, the fibronectin II-like domain in the catalytic site of the enzyme is hidden, and the fibronectin II-like-mediated binding to gelatin and collagen is prevented. However, a fraction of the pro-MMP-9.PG heteromers interacted with gelatin and collagen. This interaction was not through the chondroitin sulfate (CS) part of the PG molecule but, rather, through a region in the PG core protein, a new site induced by the interaction of pro-MMP-9 and the PG core protein, or a non-CS glycosaminoglycan part of the PG molecule. The interaction between pro-MMP-9.PG heteromers and gelatin was weaker than the interaction between pro-MMP-9 and gelatin. In contrast, collagen I bound to pro-MMP-9.PG heteromers and pro-MMP-9 with approximately the same affinity. Removal of CS chains from the PG part of the heteromers did not affect the binding to gelatin and collagen. Although the identity of the PG core protein is not known, this does not have any impact on the described biochemical properties of the heteromer or its pro-MMP-9 component. It is also shown that a small fraction of the PG, which is not a part of the pro-MMP-9.PG heteromer, can bind gelatin. As for the pro-MMP-9.PG heteromers, this was independent of the CS chains. The structure that mediates the binding of free PG to gelatin is different from the corresponding structure in the pro-MMP-9.PG heteromer, because they were eluted from gelatin-Sepharose columns under totally different conditions. Although only a small amount of pro-MMP-9.PG heteromer is formed, the heteromer may have fundamental physiological importance, because only catalytic amounts of the enzyme are required to digest physiological targets.
authors: Department of Medical Biochemistry, Institute of Medical Biology, University of Tromsø, MH Building, Tromsø 9037, Norway.
authors: Nabin
authors: N
authors: Malla
authors: Eli
authors: E
authors: Berg
authors: Lars
authors: L
authors: Uhlin-Hansen
authors: Jan-Olof
authors: JO
authors: Winberg
mesh_terms: D000818:Animals; D002384:Catalysis; D002417:Cattle; D002460:Cell Line; D011508:Chondroitin Sulfate Proteoglycans / Q000737:chemistry; D003094:Collagen / Q000737:chemistry* / Q000378:metabolism; D004792:Enzyme Precursors / Q000737:chemistry* / Q000378:metabolism; D005353:Fibronectins / Q000737:chemistry; D005780:Gelatin / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000737:chemistry* / Q000378:metabolism; D008954:Models, Biological; D009000:Monocytes / Q000378:metabolism; D011485:Protein Binding; D012685:Sepharose / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000737:chemistry
chemical_list: D011508:Chondroitin Sulfate Proteoglycans; D004792:Enzyme Precursors; D005353:Fibronectins; D005780:Gelatin; D003094:Collagen; D012685:Sepharose; C120487:pro-matrix metalloproteinase 9; D020780:Matrix Metalloproteinase 9; D013755:Tetradecanoylphorbol Acetate